| http://www.w3.org/ns/prov#value | - So this trial we are doing in pancreatic cancer, we chose because we had very good results in pancreatic cancer model and so these models actually showed us that we had particularly in combination we could really significantly show advantages over the current combination therapies or single agent therapies.
|
